Related Experiment Videos
[Cortical thrombophlebitis and developmental venous anomalies]
S Thobois1, N Nighoghossian, J F Mazoyer
1Centre d'urgences cérébro-vasculaires, Hôpital Neurologique Pierre Wertheimer, Lyon.
Revue Neurologique
|March 27, 1999
Summary
Cerebral venous angiomas, a type of abnormal intracranial venous drainage, can lead to seizures or hemorrhage. This case shows anticoagulant therapy may be beneficial for associated cortical thrombophlebitis, despite bleeding risks.
Area of Science:
- Neurology
- Vascular Malformations
Background:
- Cerebral venous angiomas (CVAs) are rare vascular malformations characterized by abnormal intracranial venous drainage.
- CVAs are typically asymptomatic but can present with neurological deficits such as hemorrhage or seizures.
- Thrombosis is an uncommon presentation of CVAs.
Observation:
- A 25-year-old woman presented with cortical thrombophlebitis.
- The thrombophlebitis was secondary to underlying developmental venous anomalies, a type of CVA.
- The patient was treated with anticoagulant therapy.
Findings:
- The patient experienced a positive outcome following anticoagulant therapy.
- This suggests that anticoagulation can be a viable treatment option for cerebral venous angioma-associated cortical thrombophlebitis.
- The treatment was successful despite the inherent risk of hemorrhage associated with CVAs.
Implications:
- Anticoagulant therapy may be indicated in select cases of cerebral venous angioma-related cortical thrombophlebitis.
- This challenges the conventional approach of avoiding anticoagulation due to hemorrhage risk.
- Further research is warranted to establish guidelines for anticoagulation in CVA patients with thrombotic complications.